Scientists identify progenitor cells that could revolutionize osteoarthritis treatment

Researchers report that osteoarthritis is caused by the loss of Gremlin 1 (Grem1)-lineage chondrogenic progenitor cells.

FDA lays out postmarketing approaches for data collection from underrepresented groups

The FDA on Thursday published draft guidance on considerations for postmarket studies on populations that were underrepresented in premarket trials. The agency tells sponsors to

August 11, 2023

Unleashing the Dynamic Force of AI and Automation to Revolutionize Revenue Cycle Management

Arnab Sen, Chief Strategy Officer, Omega Healthcare Every year, hospitals across the United States, regardless of their size or type, face significant financial losses amounting

June 28, 2024

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

New U.S. study finds mRNA-1273.815, a monovalent vaccine targeting the Omicron XBB.1.5 variant, generates higher neutralizing antibody titers compared to its bivalent counterpart. The study

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.